9:01AM ET 6/13/2022 MT NewswiresHomology Medicines (FIXX) said Monday that the US Food and Drug Administration has lifted a clinical hold on a trial of the company's HMI-102...
4:48AM ET 5/17/2022 MT NewswiresHomology Medicines (FIXX) has an average rating of outperform and price targets ranging from $4 to $29, according to analysts polled by Capital IQ. (MT...
11:07AM ET 4/28/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
9:26AM ET 4/06/2022 MT NewswiresHomology Medicines (FIXX) has an average rating of outperform and price targets ranging from $4 to $29, according to analysts polled by Capital IQ. (MT...